19-40472853-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020971.3(SPTBN4):​c.169+63C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,412,712 control chromosomes in the GnomAD database, including 18,997 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 3018 hom., cov: 30)
Exomes 𝑓: 0.14 ( 15979 hom. )

Consequence

SPTBN4
NM_020971.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.633

Publications

0 publications found
Variant links:
Genes affected
SPTBN4 (HGNC:14896): (spectrin beta, non-erythrocytic 4) Spectrin is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton, and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. It is composed of two antiparallel dimers of alpha- and beta- subunits. This gene is one member of a family of beta-spectrin genes. The encoded protein localizes to the nuclear matrix, PML nuclear bodies, and cytoplasmic vesicles. A highly similar gene in the mouse is required for localization of specific membrane proteins in polarized regions of neurons. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SPTBN4 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with hypotonia, neuropathy, and deafness
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Illumina, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-40472853-C-T is Benign according to our data. Variant chr19-40472853-C-T is described in ClinVar as Benign. ClinVar VariationId is 1224590.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020971.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN4
NM_020971.3
MANE Select
c.169+63C>T
intron
N/ANP_066022.2Q9H254-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN4
ENST00000598249.6
TSL:1 MANE Select
c.169+63C>T
intron
N/AENSP00000469242.1Q9H254-1
SPTBN4
ENST00000352632.7
TSL:5
c.169+63C>T
intron
N/AENSP00000263373.2Q9H254-1
SPTBN4
ENST00000595535.5
TSL:5
c.169+63C>T
intron
N/AENSP00000470693.1M0QZQ3

Frequencies

GnomAD3 genomes
AF:
0.184
AC:
27840
AN:
151508
Hom.:
3011
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.291
Gnomad AMI
AF:
0.162
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.00617
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.0930
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.159
Gnomad OTH
AF:
0.200
GnomAD4 exome
AF:
0.143
AC:
180771
AN:
1261090
Hom.:
15979
AF XY:
0.146
AC XY:
90018
AN XY:
616152
show subpopulations
African (AFR)
AF:
0.287
AC:
7918
AN:
27554
American (AMR)
AF:
0.0968
AC:
2704
AN:
27940
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
2399
AN:
20568
East Asian (EAS)
AF:
0.00355
AC:
122
AN:
34324
South Asian (SAS)
AF:
0.224
AC:
15388
AN:
68780
European-Finnish (FIN)
AF:
0.0982
AC:
4342
AN:
44212
Middle Eastern (MID)
AF:
0.179
AC:
645
AN:
3598
European-Non Finnish (NFE)
AF:
0.142
AC:
139663
AN:
982256
Other (OTH)
AF:
0.146
AC:
7590
AN:
51858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6848
13696
20544
27392
34240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5102
10204
15306
20408
25510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.184
AC:
27880
AN:
151622
Hom.:
3018
Cov.:
30
AF XY:
0.179
AC XY:
13292
AN XY:
74124
show subpopulations
African (AFR)
AF:
0.291
AC:
11990
AN:
41240
American (AMR)
AF:
0.129
AC:
1962
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
453
AN:
3466
East Asian (EAS)
AF:
0.00599
AC:
31
AN:
5176
South Asian (SAS)
AF:
0.222
AC:
1063
AN:
4794
European-Finnish (FIN)
AF:
0.0930
AC:
980
AN:
10534
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.159
AC:
10783
AN:
67886
Other (OTH)
AF:
0.199
AC:
418
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1067
2135
3202
4270
5337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
190
Bravo
AF:
0.189
Asia WGS
AF:
0.118
AC:
410
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.5
DANN
Benign
0.62
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62106997; hg19: chr19-40978760; COSMIC: COSV58951212; API